{"result": "(\"entity\"<|>M.ª NURIA VIRGILI CASAS<|>PERSON<|>M.ª Nuria Virgili Casas is an author and researcher associated with the study of nutrition and dietetics, particularly in relation to quilothorax and chylous ascites.)\n##\n(\"entity\"<|>RAFAEL LÓPEZ URDIALES<|>PERSON<|>Rafael López Urdiales is a co-author and researcher in the field of nutrition and dietetics, contributing to the understanding of metabolic disorders.)\n##\n(\"entity\"<|>EVA MARÍA GARCÍA RAIMUNDO<|>PERSON<|>Eva María García Raimundo is a researcher and co-author focused on clinical nutrition and its implications in metabolic disorders.)\n##\n(\"entity\"<|>MÓNICA MONTSERRAT GIL DE BERNABÉ<|>PERSON<|>Mónica Montserrat Gil de Bernabé is a co-author and researcher in the field of nutrition, particularly in relation to dietary treatments.)\n##\n(\"entity\"<|>HOSPITAL UNIVERSITARI DE BELLVITGE<|>ORGANIZATION<|>Hospital Universitari de Bellvitge is a hospital located in Hospitalet de Llobregat, Barcelona, specializing in endocrinology and nutrition.)\n##\n(\"entity\"<|>QUILOTÓRAX<|>EVENT<|>Quilotórax is a medical condition characterized by the accumulation of chyle in the pleural cavity, often requiring dietary modifications for treatment.)\n##\n(\"entity\"<|>ASCITIS QUILOSA<|>EVENT<|>Ascitis quilosa is a condition involving the accumulation of chyle in the abdominal cavity, often associated with lymphatic system disorders.)\n##\n(\"entity\"<|>TRIGLICÉRIDOS DE CADENA LARGA<|>EVENT<|>Triglicéridos de cadena larga are a type of fat that is significant in the context of chylothorax and chylous ascites, influencing dietary treatment strategies.)\n##\n(\"relationship\"<|>M.ª NURIA VIRGILI CASAS<|>HOSPITAL UNIVERSITARI DE BELLVITGE<|>M.ª Nuria Virgili Casas is affiliated with the Hospital Universitari de Bellvitge, contributing to research in nutrition and dietetics<|>7)\n##\n(\"relationship\"<|>RAFAEL LÓPEZ URDIALES<|>HOSPITAL UNIVERSITARI DE BELLVITGE<|>Rafael López Urdiales is affiliated with the Hospital Universitari de Bellvitge, contributing to research in nutrition and dietetics<|>7)\n##\n(\"relationship\"<|>EVA MARÍA GARCÍA RAIMUNDO<|>HOSPITAL UNIVERSITARI DE BELLVITGE<|>Eva María García Raimundo is affiliated with the Hospital Universitari de Bellvitge, contributing to research in nutrition and dietetics<|>7)\n##\n(\"relationship\"<|>MÓNICA MONTSERRAT GIL DE BERNABÉ<|>HOSPITAL UNIVERSITARI DE BELLVITGE<|>Mónica Montserrat Gil de Bernabé is affiliated with the Hospital Universitari de Bellvitge, contributing to research in nutrition and dietetics<|>7)\n##\n(\"relationship\"<|>QUILOTÓRAX<|>TRIGLICÉRIDOS DE CADENA LARGA<|>Quilotórax is related to the management of triglycerides of long-chain fatty acids in dietary treatments<|>5)\n##\n(\"relationship\"<|>ASCITIS QUILOSA<|>TRIGLICÉRIDOS DE CADENA LARGA<|>Ascitis quilosa is influenced by dietary management of triglycerides of long-chain fatty acids<|>5)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: renoleukodystrophy, mannosidosis, fucosidosis, aspartylglucosa-minuria, Hurler, Maroteaux-Lamy and Sly síndromes and gaucher disease type III. Curr Opin Neurol 1999; 12: 167-176.\n\n24. Moser HW. Therapy of X-linked adrenoleukodystrophy. Neuro Rx 2006; 3: 246-253.\n\n25. Semmler A, Köhler W, Jung HH, Weller M, Linnebank M. Therapy of X-linked adrenoleukodystrophy. Expert Rev Neurother. 2008 Sep;8(9):1367-79.\n\n26. Berger J, Pujol A, Aubourg P, Fors-Petter S. Current and future pharmacological treatment strategies in X-linked adrenoleukodystrophy. Brain Pathol 2010; 20: 845-56\n\n27. Sigh I, Khan M, Key L, Pai S. Lovastatin for x-linked adrenoleukodystrophy. NEJM 1988; 339: 702-2.\n\n28. Kemp S, Wei HM, Lu JF. Gene redundancy and pharmacological gene therapy: implications for x-linked adrenolukodystrophy. Nat Med 1998; 4: 1261-8.\n\n29. Peña-Quintana L, Sanjurjo Crespo P. Alteraciones de la β-oxidación y del sistema carnitina. En: Sanjurjo, Balldellou (ed). Diagnóstico y tratamiento de las enfermedades metabólicas hereditarias. Madrid, editorial Ergon, 2006.\n\n30. Peña-Quintana L. Trastorno de la oxidación de los ácidos grasos. Pediatr Integral 2002; 6: 703-10.\n\n31. Ruiz Pons M, Sánchez-Valverde F, Dalmau J, Gómez L. Errores innatos del metabolismo de las grasas En: Ruiz M, Sánchez Valverde F, Dalmau J, Gómez L (eds) Tratamiento nutricional de los errores innatos del metabolismo. Madrid, Editorial Drug Farma 2007.\n\n32. Virgili N, Forga M, García-Raimundo EM. Dieta controlada en triglicéridos de cadena larga y en triglicéridos de cadena media. En: Salas J, Bonada A, Trallero R, Saló ME, Burgos R Eds. Nutrición y Dietética Clínica. Madrid, Editorial Masson, Barcelona 2014.\n---\n# Tema 21.\n## Quilotórax y ascitis quilosa. Dietas modificadas en triglicéridos de cadena larga y cadena media\n\nM.ª Nuria Virgili Casas\nRafael López Urdiales\nEva María García Raimundo\nMónica Montserrat Gil de Bernabé\nUnidad de Nutrición y Dietética. Servicio de Endocrinología y Nutrición.\nHospital Universitari de Bellvitge. Hospitalet de Llobregat. Barcelona\n\nDietoterapia, nutrición clínica y metabolismo. Tercera edición. Copyright 2017 de los autores, SEEN y Grupo Aula Médica.\nTodos los derechos reservados. Páginas 353-363.\n\n1. Introducción\n2. Manifestaciones clínicas\n3. Diagnóstico\n4. Repercusión nutricional e inmunológica de las lesiones del sistema linfático\n5. Tratamiento\n6. Resumen y conclusiones\n7. Bibliografía\n\n### 1. Introducción\n\nEl quilo es un líquido que contiene en suspensión los productos de la digestión y absorción de la grasa contenida en los alimentos y especialmente los triglicéridos de cadena larga (TCL). Es transportado por los conductos linfáticos a la circulación a través del conducto torácico. Aproximadamente entre el 70-90% de la grasa ingerida circula a través de este sistema.\n\nLos conductos linfáticos actúan como mecanismo de drenaje facilitando el retorno de fluidos, lípidos y proteínas desde los tejidos al sistema vascular a través de la cisterna quilosa y el conducto torácico. La cisterna quilosa está formada por tres troncos linfáticos: dos troncos lumbares de cada una de las extremidades inferiores y un tronco intestinal (fig. 1). De la cisterna quilosa deriva el conducto torácico que entra en el tórax a través del hiato aórtico ascendiendo por el mediastino posterior en el hemitórax derecho hasta la cuarta o quinta vértebra torácica, en que pasa al hemitórax izquierdo, anterior a la arteria subclavia y desemboca en el sistema venoso en la confluencia de la vena subclavia y la vena yugular interna izquierdas. Variantes anatómicas son frecuentes, por lo que en el 40-60% de los individuos pueden tener colaterales anómalas del conducto torácico. Esta puede ser una\n\n| Figura 1. Anatomía del sistema linfático y\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}